PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)
Sun Young Rha(Yonsei University), Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center), Laura H. Tang(Memorial Sloan Kettering Cancer Center), Ting Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fatemeh G. Amlashi(The University of Texas MD Anderson Cancer Center), Senaka Peter(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dipen M. Maru(The University of Texas MD Anderson Cancer Center), Geoffrey Y. Ku(Memorial Sloan Kettering Cancer Center), Carly Fein(Memorial Sloan Kettering Cancer Center), Hyun Cheol Chung(Yonsei University), Wei Zhou(Broad Institute), Han Sang Kim(Yonsei University), Mary J. Savage(Merck & Co., Inc., Rahway, NJ, USA (United States)), D. Kelsen(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 5
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.7k